Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
Newsfilter· 2024-08-06 21:00
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to a report from Mordor Intelligence, the Alzheimer's Disease Diagnostics And Therapeutics Market size is estimated at USD 7.70 billion in 2024, and is expected to reach USD 10.10 billion by 2029, growing at a CAGR of 5.57% during the forecast period (2024-2029). The report said: "The major factors driving the growth of the Alzheimer's disease diagnostics and therapeutics market are the increasing use of biomarker ...
Mawson Infrastructure Group Inc. to Present at the 2024 Gateway Conference in San Francisco, CA
Newsfilter· 2024-08-06 20:45
MIDLAND, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) ("Mawson" or "the Company"), a publicly traded digital infrastructure company, announced that it will be presenting at the 2024 Annual Gateway Conference, which is being held September 4-5 in San Francisco, CA. Mawson's CEO and President, Rahul Mewawalla, is scheduled to present and speak on Thursday, September 5th at 10:00 a.m. Pacific Time (PT) or 1:00 p.m. Eastern Time (ET). For additional information, please ...
SELLAS Receives EMA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas
Newsfilter· 2024-08-06 20:45
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) for SLS009, a novel, and highly selective CDK9 inhibitor, for the treatment of relapsed/refractory (r/r) peripheral T-cell lymphomas (PTCL). "We are pleased t ...
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
Newsfilter· 2024-08-06 20:45
PALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - The demand for antiviral drugs has been increasing globally due to the growing prevalence of viral diseases. Customers are increasingly seeking antiviral drugs that are effective against a wide range of viruses and have minimal side effects. They also prefer drugs that are easy to administer and have a shorter treatment duration. The Antiviral Drugs segment is expected to experience significant growth, which is main ...
ArcBest Joins the TriumphPay Network to Enhance Carrier Payments
Newsfilter· 2024-08-06 20:35
DALLAS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- TriumphPay announced today the addition of ArcBest® (NASDAQ:ARCB), a multibillion-dollar integrated logistics company offering one of the largest freight brokerages in North America, to TriumphPay as a full audit and payments network participant. ArcBest, a leader in the transportation and logistics industry, joins the network as part of its strategy to better serve carriers, improve operational efficiency and enhance payment security. This customer alliance builds ...
Expion360 Partners with K-Z Recreational Vehicles, a Division of Thor Industries, Inc., to Provide Advanced Lithium Battery Solutions
Newsfilter· 2024-08-06 20:31
REDMOND, Ore., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Expion360 Inc. (NASDAQ:XPON) ("Expion360" or the "Company"), an industry leader in lithium-ion battery power storage solutions, today announced a partnership with K-Z Recreational Vehicles ("K-Z RV"), a subsidiary of Thor Industries, Inc. This collaboration will integrate Expion360's cutting-edge battery technology into K-Z RV's premium offerings, enhancing the offgrid capabilities of their vehicles. K-Z RV's Boondocker package, renowned for its exceptional o ...
Perma-Fix Schedules Second Quarter 2024 Business Update Conference Call
Newsfilter· 2024-08-06 20:30
ATLANTA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the "Company") today announced it will host a conference call at 11:00 AM Eastern Time on Thursday, August 8, 2024. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2243/51027 or in the investor section of the Company's website at https://ir.perma-fix.com/conference-calls. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 ...
Complete Solaria Discusses SunPower Acquisition Opportunity
Newsfilter· 2024-08-06 20:30
LEHI, Utah, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Complete Solaria, Inc. ("Complete Solaria" or the "Company") (NASDAQ:CSLR), a leading solar technology, services, and installation company, today announced that it had received a coveted "Stalking Horse" position in the SunPower (NASDAQ:SPWR) Chapter 11 bankruptcy (https://newsroom.sunpower.com/2024-08-05-SunPower-Announces-Stalking-HorseAsset-Purchase-Agreement-with-Complete-Solaria-to-Sell-Blue-Raven-Solar,-New-Homes,-and-its-NonInstalling-Dealer-Network). As ...
Ispire Technology Inc. Signs Exclusive 30-Year Global Manufacturing and Distribution Agreement with US-Based Lifestyle Brand Hidden Hills Club
Prnewswire· 2024-08-06 20:30
核心观点 - Ispire Technology Inc.子公司与Hidden Hills Club签订30年全球独家许可协议,标志着Hidden Hills Club进军全球尼古丁产品市场,Ispire将负责生产、分销和商业化Hidden Hills品牌的尼古丁产品[1][2] Ispire Technology Inc.相关 - 是电子烟技术研发、设计和创新的领导者,制定了全球汽化产品的行业标准,拥有200多项已颁发专利和800多项在审专利,获得多个著名电子烟奖项,经营子公司在全球拥有或授权400多项专利[4][6] - 将在全球制造、分销和商业化Hidden Hills品牌的尼古丁产品,如低风险电子烟,初期产品将在阿联酋和南非推出,随后在英国和欧盟推出,还计划扩大现有产品供应[2] - 其联合首席执行官表示合作能将创新和低风险尼古丁产品推向全球,30年独家许可将使公司对Hidden Hills品牌进行重大投资,确保强大的分销和丰富的产品组合[3] Hidden Hills Club相关 - 是一个美国生活方式品牌,涵盖服装、大麻和 hemp产品等,过去两年呈指数级增长[3] - 其首席执行官称与Ispire合作是战略决策,Ispire的技术专长和全球分销网络为其品牌进军尼古丁产品市场提供了完美平台[3] 市场相关 - 2024年电子蒸汽和大麻蒸汽市场预计分别达到299亿美元和116亿美元,受更健康烟草替代品的长期趋势驱动[4]
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
Prnewswire· 2024-08-06 20:30
TORONTO and GLIL YAM, Israel, Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2024 ended June 30, 2024, on Wednesday, August 14, 2024, before the market opens. The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for ...